Vitreous opacities after intravitreal triamcinolone injection- a case report

BMC Ophthalmology

Table 1 Demographic details, indications and the number of days the vitreous opacities were seen to be persisting after the triamcinolone acetonide injection in the vitreous

Sr No	Age	Sex	Eye	Indication	Lens status	Procedure	Dose	Follow up of vitreous opacities in days	Other complications
1	66	M	OS	DME	Pseudophake	PE + IOL + IVTA	2 mg	91	None
2	59	M	OS	DME	Phakic	IVTA	4 mg	218	Steroid induced glaucoma
3	59	M	OD	DME	Phakic	IVTA	2 mg	188	Steroid induced glaucoma
4	43	F	OS	Pseudophakic-CME	Pseudophake	IVTA	2 mg	305	None
5	54	F	OS	Pseudophakic-CME	Pseudophake	IVTA	2 mg	189	None
6	66	M	OS	DME	Pseudophake	IVTA	2 mg	425	None
7	47	F	OS	STBRVO-CME	Pseudophake	IVTA	2 mg	216	None
8	68	M	OS	DME	Pseudophake	IVTA	2 mg	344	None

OD right eye, OS left eye, DME diabetic macular edema, CME cystoid macular edema, STBRVO superotemporal branch vein occlusion, PE phacoemulsification, IOL intraocular lens, IVTA intravitreal triamcinolone acetonide

ISSN: 1471-2415